StressMarq Biosciences
banner
stressmarq.bsky.social
StressMarq Biosciences
@stressmarq.bsky.social
Dedicated to advancing the frontiers of neurodegenerative disease research. 🧠

Innovative product portfolio including pre-formed fibrils (PFFs), oligomers, & monomers for alpha synuclein, tau, & amyloid beta for use in disease modelling & drug discovery.
Product Citation 🍎 StressMarq's #AlphaSynuclein Aggregate Antibody was employed by neuroscientists in China to evaluate the effects of chronic intermittent #hypoxia (CIH) on αSyn expression, neuronal function & cognitive ability.

Paper 📕 https://bit.ly/3JFbmcC
Product 🧧 https://bit.ly/3XfzwgR
November 13, 2025 at 12:30 AM
StressMarq will be exhibiting at #Neuroscience 2025 from November 16-19 in San Diego, California🌅. Come by and visit Booth 822 to learn about our comprehensive portfolio of products for neuroscience research! #SfN2025 #neuroscience

Learn more🧪http://bit.ly/4qoGnSG
November 12, 2025 at 12:23 AM
Product Citation ✨

A study from the University of Alabama at Birmingham used StressMarq's NKCC2 Antibody to examine the impact of aquaporin insertion and diurnal patterns on fluid-electrolyte balance.

Paper 🌊 https://bit.ly/47YjP3V
Product 💧 https://bit.ly/3WG1AtG
November 8, 2025 at 6:18 PM
StressMarq will be exhibiting at #Neuroscience 2025 from November 16-19 in San Diego, California🌅. Come by and visit Booth 822 to learn about our comprehensive portfolio of products for neuroscience research! #SfN2025 #neuroscience

Learn more🧪http://bit.ly/4qoGnSG
November 7, 2025 at 12:23 AM
Product Citation 💡

Researchers at the University of Pittsburgh utilized StressMarq's ENaC gamma Antibody to identify Na+ transport through ENaC and the Na+/K+ ATPase as targets of inhibition by canagliflozin. #KidneyResearch

Paper 🧪 https://bit.ly/4oiRyea
Product 🔬 https://bit.ly/4ottRQz
November 6, 2025 at 9:41 PM
Product Citation 🍁 Researchers at the University of Alberta probed the connection between mutations in TMX2 & mitochondrial hyperactivity in #neurodevelopmental disorders, using StressMarq's ERp57 Antibody.

Paper 🌲 https://bit.ly/437ZW7R
Product 🌿 https://bit.ly/3vLSYbj
November 6, 2025 at 5:46 PM
StressMarq will be exhibiting at #Neuroscience 2025 from November 16-19 in San Diego, California🌅. Come by and visit Booth 822 to learn about our comprehensive portfolio of products for neuroscience research! #SfN2025 #neuroscience

Learn more🧪http://bit.ly/4qoGnSG
November 1, 2025 at 11:23 PM
Product Citation 🌟 A research team @mayoclinic.org investigated mechanisms driving #LewyBody pathology using a novel split biotin ligase technique. StressMarq’s #AlphaSynuclein PFFs were employed to model aggregation in vitro.

Paper 🌿https://bit.ly/4hB0VDy
Product 🌼 https://bit.ly/2u9YHV2
October 30, 2025 at 4:46 PM
StressMarq was proud to exhibit with #Neobioscience at the 9th Annual Meeting of the #Neurodegenerative Diseases Branch of the Chinese #Neuroscience Society! A great chance to engage with researchers, share our tools for #neuro research, and foster #GlobalScience collaboration. 🧠✨
October 29, 2025 at 5:30 PM
Product Citation ✨ Researchers from Southwest Medical University used Stressmarq's Calreticulin Antibody to analyze the optimal therapeutic sequence of rhGM-CSF and #radiotherapy in treating pancreatic cancer.

Paper🔬 http://bit.ly/3WQy7x5
Product🧪 http://bit.ly/3J9uP53
October 25, 2025 at 5:18 PM
Product Citation💡A study out of Vanderbilt University used StressMarq's NHE3 #Antibody to examined how a dominant-negative Kir5.1 channel reduces kidney K+ flux.

Full Paper💐 http://bit.ly/3WRq2IB
Product Details🌺 https://bit.ly/3ICiiD8
October 24, 2025 at 11:17 PM
Product Citation🌟A study from the University of Iowa used StressMarq's tau Antibody to examine how tau-mediated dysfunction within the dorsal raphe nucleus promotes the spread of ptau in #Alzheimer's disease.

Paper📘http://bit.ly/4oAQzG1
Product🔬http://bit.ly/48KJLRs
October 23, 2025 at 8:41 PM
A collaborative study between @ucl.ac.uk, @crick.ac.uk, and KAIST examined how astrocytes shift to neurotoxic states in #Parkinson’s disease, with #AlphaSynuclein and ADAR1 RNA editing driving inflammation.

Read about it on the blog📚 http://bit.ly/4qmdXc3
October 22, 2025 at 5:04 PM
Product Citation💡 Researchers at @ucsandiego.bsky.social used StressMarq's Anti-HSP90 Antibody to identify NUAK family kinase 2 as a fetal oncogene for #glioblastoma multiforme in mouse and human brains.

Full paper 📘 http://bit.ly/3KTyc0t
Product details 🔬 http://bit.ly/3J1ReRN
October 21, 2025 at 11:09 PM
Product Citation 🌟 A study out of the University of Utah used StressMarq's Anti-ENaC alpha Antibody to examine aldosterone-targeted therapies for chronic #hypertension and kidney disease.

Full paper 📚 http://bit.ly/3W7zPtT
Product details 🧫 http://bit.ly/4ooJ6cS
October 17, 2025 at 11:17 PM
Product Citation: Coordination of #Anle138b with silver yields a novel compound that selectively reduces C-terminally truncated αSyn in a Parkinson's disease model employing StressMarq’s #AlphaSynuclein PFFs.

Paper 🏝️ https://bit.ly/3KKfR62
Product 🌊 https://bit.ly/2u9YHV2
##neurodegeneration
October 16, 2025 at 8:41 PM
Product Citation: New research reveals that traumatic brain injury impairs microglial #phagocytosis and disrupts neuronal activity. Post-impact acrolein accumulation was identified using StressMarq's #Acrolein Antibody.

Paper 🪐 https://bit.ly/46GzS5T
Product details 📚 https://bit.ly/3OreOXF
October 16, 2025 at 4:46 PM
🧪Researchers at the University of Washington studying #Alzheimer's disease linked mutations in the SORL1 gene to lysosome malfunction in microglia, highlighting lysosomal pathways as a therapeutic target.

🔎Read about it on the blog: http://bit.ly/46K4oMi
October 14, 2025 at 6:07 PM
🔎Did you know?

RRIDs are ID numbers that researchers use to cite key resources, increasing transparency in #scientific literature. All StressMarq antibodies have RRIDs, which can be found on our website.

🔬Our antibodies: http://bit.ly/3J0Wl4y
📚About RRIDs: http://bit.ly/3Wvtkkx
October 11, 2025 at 5:18 PM
Product Citation: Proteomic analysis identified pyroxamide as a potential #neuroprotective agent in Parkinson's disease. StressMarq's #AlphaSynuclein A53T PFFs were used to examine its effects in an in vitro model of #PD.

Paper 💡 https://bit.ly/46XxV3O ##αSyn PFFs 🌐 https://bit.ly/2GREQ4c
October 7, 2025 at 11:09 PM
📫 The September edition of 'What's New at StressMarq?' is here! Read about our new #TDP43 Hexamutant Monomers, learn more about an exciting recent collaborative study, and stay up to date with our upcoming products & latest blog posts.

🔗 Read it here: https://bit.ly/47PsKoO
September 22, 2025 at 10:35 PM
Investigators developed a unique peptide-based fluorescent probe for the rapid and specific labelling of alpha synuclein aggregates, using StressMarq's Mouse #AlphaSynuclein PFFs.

Full paper👉 https://bit.ly/4aqc45Y
α-Syn Pre-formed Fibrils: https://bit.ly/2HJyYee
September 19, 2025 at 11:17 PM
Product Citation: #AmyloidBeta 1-42 drives #Alzheimers disease pathology. Novel findings using StressMarq’s Amyloid Oligomers (A11) Antibody show that bovine #fibrinogen binds #Aβ42, suppressing fibril formation & reducing toxicity.

Paper 🌱 https://bit.ly/41MbX26
Product ✨ https://bit.ly/48HbvTw
September 10, 2025 at 1:16 PM
By delivering therapeutic agents via PLGA nanoparticles, scientists at the University of Alberta, Canada observed a significant reduction in #tau aggregation, suggesting a promising route for targeted treatment of #neurodegenerative diseases.

Learn more on the blog 🍁 https://bit.ly/46hrbxF
August 27, 2025 at 6:39 PM
Product Citation: StressMarq’s #AlphaSynuclein PFFs were utilized to evaluate a novel α-synuclein-specific epitope vaccine, which demonstrated therapeutic potential by alleviating Parkinson’s disease-related pathophysiology in mouse models. #PD

Paper👉 bit.ly/3RMTC0d
α-Syn PFFs: bit.ly/2u9YHV2
August 26, 2025 at 4:49 PM